Benadryl

Mixed Glioma

City of Hope Medical CenterPhase 1Dormant

CC

47/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 32/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Mixed Glioma cohort.

Asset / Sponsor	Phase	Rating
Inno-206 Washington University School of Medicine	Phase 2	CCC
ETOPOSIDE Washington University School of Medicine	Phase 2	CCC
Lopinavir Case Comprehensive Cancer Center	Phase 2	CCC
RITONAVIR Case Comprehensive Cancer Center	Phase 2	CCC
FLUTICASONE Roswell Park Cancer Institute	Phase 1	CC

View all 11 →

Same molecule, other indications

Benadryl is also rated in:

Relapsing Chronic Myelogenous LeukemiaDormant

BBB

Indicative ·

74 / 100

Recurrent Adult Hodgkin LymphomaDormant

BBB

Indicative ·

74 / 100

Recurrent Adult Acute Myeloid LeukemiaDormant

BBB

Indicative ·

72 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.